Richard Marshak's most recent trade in TriSalus Life Sciences Inc was a trade of 21,428 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 5.18 per share. | 19 May 2025 | 21,428 | 75,698 | - | 5.2 | 110,997 | Common Stock |
TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 19 May 2025 | 6,597 | 69,101 | - | 5.2 | 34,172 | Common Stock |
TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 7,644 | 54,270 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 46,626 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 41,250 | 41,250 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 6,875 | 34,126 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Richard Marshak | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 14,752 | 27,251 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Marshak Richard | SR.VP, CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Richard Marshak | Sr.VP, Corp. Dev. & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |